688319.SS Chengdu Olymvax Biopharmaceuticals Inc.

Hong Kong-listed Shanghai Henlius Biotech Inc, a subsidiary of Fosun Pharma, announced on Wednesday that its anti-PD-1 mAb, HANSIZHUANG, or serplulimab, has been approved by the European Commission to ...

[Photo provided to chinadaily.com.cn] Hong Kong-listed Shanghai Henlius Biotech Inc, a subsidiary of Fosun Pharma, held its 2025 Global R&D Day with the theme of "collaborate to create" in Shanghai on ...

9IP1.F Rocket Pharmaceuticals, Inc.

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Department of Ophthalmology, Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, People’s Republic of China Shanghai Key Laboratory of Orbital Diseases and ...

& Ming-Ju Hsieh Article 22 May 2025 | Open Access A comparison of genomic methods to assess DNA replication timing Emily Wheeler, Leigh Mickelson-Young & Linda Hanley-Bowdoin Article ...

The Col­umn Group’s drug R&D team, known as TCG Labs Soleil, has been busy churn­ing out new port­fo­lio com­pa­nies since it un­veiled with a … ...

Key Laboratory of the Ministry of Education for Advanced Catalysis Materials, Institute of Physical Chemistry, Zhejiang Normal University, Jinhua 321004, China ...